ClinicalTrials.Veeva

Menu
M

Medical University of Innsbruck | Neurology Clinic

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Survodutide
Nintedanib
Dabigatran Etexilate
Atezolizumab
BI 425809
Lucitanib
Chemotherapy+Bevacizumab
Candesartan
BI 685509
Ropivacaine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 95 total trials

A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT-URGE)

A study to investigate bowel urgency in adults with moderately to severely active ulcerative colitis (UC) treated with mirikizumab. The study will ha...

Active, not recruiting
Ulcerative Colitis Chronic
Ulcerative Colitis
Drug: Mirikizumab

This study is open to adults with different types of advanced cancer (solid tumors) that are accessible for injection and/or biopsy. This is a study...

Enrolling
Solid Tumors
Drug: anti-PD-1 antibody
Drug: BI 1831169

This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide
Locations recently updated

This study is open to adults 18 years and older who have early-stage non-small cell lung cancer (NSCLC). Their cancer must have a specific change in...

Enrolling
Non-small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Atezolizumab

This is a phase 2, multicenter, randomized, placebo-controlled, double-blind, parallel-group, proof-of-concept study to assess vamifeport in adult pa...

Enrolling
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
Drug: Placebo
Drug: Vamifeport

Early vascular aging has its origins in fetal and neonatal life. The NEOVASC clinical trial aims to determine the effects of an exclusive human milk...

Enrolling
Prematurity
Vascular Aging
Dietary Supplement: Humavant

The EPYGON VALVE is an innovative mitral valve, intended for valve replacement of a native mitral valve through a minimally invasive implant procedur...

Enrolling
Mitral Valve Regurgitation
Device: Epygon™ Transcatheter Mitral Valve System

The goal of this clinical trial is to learn whether a hybrid multidomain lifestyle program can prevent cognitive decline and reduce dementia risk in...

Not yet enrolling
Mild Cognitive Impairment (MCI)
Subjective Cognitive Decline (SCD)
Behavioral: A tailored hybrid multidomain lifestyle intervention group
Behavioral: Self-guided multimodal lifestyle advice group

This study is open to adults who are at least 18 years old living with obesity and have:* a confirmed liver disease called non-alcoholic steatohepati...

Enrolling
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Liver Fibrosis
Drug: Survodutide
Drug: Placebo

This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...

Active, not recruiting
MSA - Multiple System Atrophy
Symptomatic Neurogenic Orthostatic Hypotension
Drug: Ampreloxetine
Drug: Placebo

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderat...

Enrolling
Ulcerative Colitis
Drug: Tilpisertib Fosmecarbil
Drug: Placebo
Locations recently updated

This study is open to adults and adolescents aged 12 to under 18 with bronchiectasis. People can participate in this study if they produce sputum and...

Enrolling
Bronchiectasis
Drug: Placebo matching BI 1291583
Drug: BI 1291583

Trial sponsors

M
Boehringer Ingelheim logo
Medical University of Vienna logo
M
Ipsen logo
A
A
I
A
CSL Behring logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems